About Venclose

Our Company

We are a medical technology company developing next-generation solutions for the treatment of chronic venous insufficiency, a progressive medical condition affecting an estimated 10% of adults.1,2

Our Mission

To improve the physician and patient experience during chronic venous insufficiency treatment by commercializing the next-generation RF therapy.

Our Values

Positive, consistent clinical outcomes
We are committed to providing reliable, safe and effective RF treatment options for physicians and their patients suffering from chronic venous insufficiency.

Strong physician partnerships
We are focused on providing world-class customer support and fostering deep relationships with physician leaders to ensure we develop meaningful solutions.

Operational excellence
We are dedicated to maximizing quality and reducing inefficiencies to ensure we deliver the highest quality products and services at the lowest possible cost.

1. Gloviczki P, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011 May;53(5 Suppl):2S-48S.
2. Evans CJ, et al. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health 1999;53:149–53.